Risk of Death Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Therapy: A Systematic Review and Meta-analysis

IMPORTANCE: Although intravitreal anti–vascular endothelial growth factor (VEGF) treatment represents the first-line therapy for many retinal diseases, the issue of their systemic safety is debatable. OBJECTIVES: To assess whether intravitreal anti-VEGF therapy might be associated with increased ris...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Ophthalmol
Autors principals: Reibaldi, Michele, Fallico, Matteo, Avitabile, Teresio, Bonfiglio, Vincenza, Russo, Andrea, Castellino, Niccolò, Parisi, Guglielmo, Longo, Antonio, Pulvirenti, Alfredo, Boscia, Francesco, Virgili, Gianni
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902107/
https://ncbi.nlm.nih.gov/pubmed/31750861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2019.4636
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars